Total Live Articles: 471

Trigeminal Neuralgia

NICE CKS Trigeminal neuralgia. Last revised: Jan 2024.

NICE Clinical guideline [CG173] Neuropathic pain in adults: pharmacological management in non-specialist settings. Last updated: Sep 2020.

Trigeminal Neuralgia

Trigeminal neuralgia is a facial pain disorder characterised by recurrent, severe, electric shock-like pain in the distribution of one or more branches of the trigeminal nerve (CN V).

This updated UKMLA guide to trigeminal neuralgia is based primarily on NICE CKS, which covers causes, risk factors, symptoms, diagnosis, and management.

Causes and Risk Factors

There are 2 main types of trigeminal neuralgia:

Classical trigeminal neuralgia Occurs due to neurovascular compression of the trigeminal nerve root, typically by an artery / vein near the pons
Secondary trigeminal neuralgia Key causes include:

Risk factors:

  • Females
  • Peak incidence: 50-60 y/o
  • Family history

Clinical Features

Disease course Recurrent and episodic – the patient may go into remission for weeks or months before returning

Pain-free periods may gradually shorten between episodes

Provoking factors Episodes may be triggered by mild stimulation of the face, such as:

  • Light touch to the face
  • Eating / chewing
  • Talking
  • Brushing teeth
  • Shaving
  • Exposure to cold air / wind
Features of a painful episode Almost always unilateral (only ~3% cases are bilateral)

  • Sudden onset and stops abruptly
  • Severe electric shock-like / sharp / shooting pain
  • Short-lived duration: a few seconds to 2 min
  • Pain usually affects the V2 and/or V3 divisions:
    • Maxillary division (V2): mid-face (including the cheek, upper lip, upper teeth / gum, side of the nose)
    • Mandibular division (V3): lower face (including the lower lip, lower jaw, chin, lower teeth / gum)
    • Ophthalmic division (V1) involvement alone is uncommon and is a red-flag feature

Some patients may experience continued aching after the acute pain has resolved

Patients may experience multiple attacks a day, with a refractory period between each attack

Mild ipsilateral autonomic symptoms, such as tearing or eye redness, may occur during painful attacks of trigeminal neuralgia.

However, prominent autonomic symptoms such as marked lacrimation, conjunctival injection, rhinorrhoea, nasal congestion, ptosis, eyelid swelling, or facial sweating are more suggestive of a trigeminal autonomic cephalalgia, such as cluster headache

Investigation and Diagnosis

Trigeminal neuralgia is primarily a clinical diagnosis, if there is an absence of red flags

Investigations are usually only needed if red flags or features of a secondary cause are present.

It is important to examine the face and oral cavity to exclude dental causes that might be contributing to the pain.

Red flags:

  • Sensory changes
  • Deafness or other ear problems
  • History of skin / oral lesions that could spread perineurally
  • Pain only in the ophthalmic division of CN V
  • Optic neuritis
  • Family history of multiple sclerosis
  • Onset <40 y/o

Management

Referral Criteria

If any of the following, admit or refer urgently for specialist assessment:

Red flag Rationale
Sensory changes Suggests nerve compression or demyelination (e.g. multiple sclerosis or tumour)
Deafness or other ear problems Possible vestibular schwannoma or other cerebellopontine angle lesion (compresses both CN V and VIII)
Pain only in the ophthalmic division of CN Possible sinonasal / orbital / intracranial pathology
Bilateral symptoms Bilateral trigeminal neuralgia is unusual and should raise suspicion for secondary causes, esp. multiple sclerosis
Optic neuritis Suggest multiple sclerosis
Family history of multiple sclerosis
Onset <40 y/o Suggest secondary causes (e.g. multiple sclerosis, genetic syndromes)
History of skin or oral lesions that could spread perineurally Possible cancer / perineural tumour spread

Pharmacological Management

1st line: carbamazepine

  • Start at 100 mg up to twice daily, then titrate upwards until pain is controlled
  • Maximum dose: 1600 mg daily

If carbamazepine is not appropriate or not effective: seek advice from secondary care (do not offer any other drug treatment unless advised by a specialist).

References


Related Articles

Cluster Headache

Bell’s palsy

Vestibular Schwannoma

Multiple Sclerosis (MS)

Neuropathic pain

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.